Kidney function may change how diabetes drug works
NCT ID NCT05292495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a single dose of HR17031 moves through the body in people with mild, moderate, severe, or end-stage kidney disease compared to those with normal kidneys. A total of 24 adults with type 2 diabetes took part. The goal was to understand how kidney function affects drug levels, not to treat the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What does life feel like for children with a rare birth defect? a new study asks
- Kidney health may change how this drug works
- Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
- Dialysis patients wear heart monitors for a week to uncover hidden risks
- New combo therapy could protect kidneys and hearts without High-Dose statins
- Ready-to-use dialysis fluids tested in real-world ICU study